Green tea phytocompounds as anticancer: A review

• Published in: Asian Pacific journal of tropical disease Vol. 6; no. 4; pp. 330 - 336
• Main Authors: Ullah, Najeeb, Ahmad, Mahboob, Aslam, Hasnain, Tahir, Muhammad Asad, Aftab, Muhammad, Bibi, Noreen, Ahmad, Sohail
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01.04.2016
• Subjects: Anticancer; Green tea; Phytocompounds; Therapeutic potential; Phytocompounds; Anticancer; Therapeutic potential; Green tea
• ISSN: 2222-1808; 2222-1808
• DOI: 10.1016/S2222-1808(15)61040-4

Green tea is universally considered significant and its benefits have been experimentally explored by researchers and scientists. Anticancer potential of green tea has been completely recognized now. Green tea contains anti-cancerous constituents and nutrients that have powerful remedial effects. By using electronic data base (1998–2015), different compounds in green tea possessing anticancer activity including epigallocatechin-3-gallate, paclitaxel and docetaxel combinations, ascorbic acid, catechins, lysine, synergistic arginine, green tea extract, proline, and green tea polyphenols has been reported. Green tea extracts exhibited remedial potential against cancer of lung, colon, liver, stomach, leukemic cells, prostate, breast, human cervical cells, head, and neck. For centuries, green tea has been utilized as medicine for therapeutic purposes. It originated in China and extensively used in Asian countries for blood pressure depression and as anticancer medicine. Green tea has therapeutic potential against many diseases such as lowering of blood pressure, Parkinson’s disease, weight loss, esophageal disease, skin-care, cholesterol, Alzheimer’s disease and diabetes.